EPS for LHC Group, Inc. (LHCG) Expected At $0.60

April 17, 2018 - By Max Morgan

LHC Group, Inc. (NASDAQ:LHCG) LogoInvestors sentiment decreased to 1.15 in Q4 2017. Its down 0.35, from 1.5 in 2017Q3. It dived, as 30 investors sold LHC Group, Inc. shares while 56 reduced holdings. 38 funds opened positions while 61 raised stakes. 15.67 million shares or 2.23% more from 15.33 million shares in 2017Q3 were reported.
Meeder Asset Mngmt Inc has 0% invested in LHC Group, Inc. (NASDAQ:LHCG) for 435 shares. Boston Advsrs Ltd Liability Corporation holds 0.01% or 10,165 shares. 17,683 are held by Kbc Nv. Pub Employees Retirement Of Ohio, a Ohio-based fund reported 113,260 shares. 5,196 were reported by Peak6 Invs Limited Partnership. Blackrock Inc reported 2.45M shares. Sei Invs Co has 101,682 shares for 0.02% of their portfolio. 5,260 are held by Metropolitan Life Ins. Dimensional Fund Advsrs L P invested in 0.03% or 1.22 million shares. Geode Capital Management Limited Liability Corporation holds 0% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG) for 143,324 shares. Riverhead Mngmt Limited Com reported 1,669 shares stake. Point72 Asia (Hong Kong) Limited invested 0% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG). Systematic Financial Mgmt L P stated it has 25,746 shares. Texas Permanent School Fund has 10,997 shares. Wellington Management Grp Llp reported 19,406 shares or 0% of all its holdings.

Since March 13, 2018, it had 0 insider buys, and 1 insider sale for $909,824 activity.

Analysts expect LHC Group, Inc. (NASDAQ:LHCG) to report $0.60 EPS on May, 2.They anticipate $0.12 EPS change or 25.00 % from last quarter’s $0.48 EPS. LHCG’s profit would be $18.72M giving it 30.08 P/E if the $0.60 EPS is correct. After having $0.62 EPS previously, LHC Group, Inc.’s analysts see -3.23 % EPS growth. The stock increased 1.52% or $1.08 during the last trading session, reaching $72.19. About 91,471 shares traded. LHC Group, Inc. (NASDAQ:LHCG) has risen 15.17% since April 17, 2017 and is uptrending. It has outperformed by 3.62% the S&P500.

LHC Group, Inc. (NASDAQ:LHCG) Ratings Coverage

Among 8 analysts covering LHC Group (NASDAQ:LHCG), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. LHC Group had 11 analyst reports since November 2, 2017 according to SRatingsIntel. The company was maintained on Tuesday, January 23 by William Blair. Oppenheimer maintained the stock with “Outperform” rating in Friday, November 17 report. The stock has “Outperform” rating by Oppenheimer on Tuesday, November 7. Craig Hallum maintained the shares of LHCG in report on Tuesday, November 7 with “Buy” rating. The stock has “Buy” rating by Stephens on Thursday, March 1. Craig Hallum maintained LHC Group, Inc. (NASDAQ:LHCG) rating on Wednesday, April 4. Craig Hallum has “Buy” rating and $8000 target. The firm earned “Buy” rating on Tuesday, November 7 by Jefferies. As per Monday, November 27, the company rating was maintained by Robert W. Baird. SunTrust maintained LHC Group, Inc. (NASDAQ:LHCG) on Thursday, November 2 with “Buy” rating. The rating was maintained by Jefferies with “Buy” on Thursday, November 2.

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company has market cap of $2.25 billion. The firm operates through four divisions: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. It has a 25.87 P/E ratio. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

LHC Group, Inc. (NASDAQ:LHCG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: